{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:23:46Z","timestamp":1785842626175,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ygyno.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T13:30:28Z","timestamp":1490707828000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer"],"prefix":"10.1016","volume":"145","author":[{"given":"S.A.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"van der Zanden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"McGahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2017.03.011_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijgo.2009.02.008","article-title":"New surgical staging of endometrial cancer: 20years later","volume":"105","author":"Mariani","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.06.019","article-title":"Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: unraveling a mystery","volume":"115","author":"Wethington","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.011_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/gyno.2001.6301","article-title":"Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators","volume":"82","author":"Takeshima","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.03.011_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2017.03.011_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0b013e3181a94568","article-title":"Stage IIIA endometrial carcinoma: outcome and predictors of survival","volume":"114","author":"Bansal","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2006.03.003","article-title":"Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?","volume":"103","author":"Saga","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.03.011_bb0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.3800342","article-title":"Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer","volume":"18","author":"Fadare","year":"2005","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2005.03.033","article-title":"Practice patterns of SGO members for stage IIIA endometrial cancer","volume":"98","author":"Lee","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.011_bb0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1525-1438.2005.15317.x","article-title":"Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy","volume":"15","author":"Slomovitz","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2017.03.011_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1097-0142(19991025)87:5<259::AID-CNCR4>3.0.CO;2-O","article-title":"Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases","volume":"87","author":"Sharifi","year":"1999","journal-title":"Cancer Cytopathol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.03.011_bb0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/AOG.0b013e3181b96ec6","article-title":"Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer?","volume":"114","author":"Kwon","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.03.011_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2013.09.012","article-title":"The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma","volume":"131","author":"Jutzi","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2017.03.011_bb0080","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"ESMO guidelines working group. endometrial cancer: eSMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.011_bb0085","author":"BC Cancer Agency Cancer Management Guidelines"},{"issue":"1","key":"10.1016\/j.ygyno.2017.03.011_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"24","author":"Randall","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.ygyno.2017.03.011_bb0095","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2013results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.03.011_bb0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.011_bb0105","author":"MSC Payment Schedule Index"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817302287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817302287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T14:29:02Z","timestamp":1601821742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817302287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0090825817302287"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}